Elliott, SP; Brandt, SD; Smith, C. The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysis Drug Test. Anal., 1 Aug 2016, 8 (8), 875-879. 791 kB. https://doi.org/10.1002/dta.1984 LC,MS,UV
EMCDDA. Report on the risk assessment of 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (AH-7921), European Monitoring Centre for Drugs and Drug Addiction, Lisbon, . 671 kB. #AH-7921 MS,IR,UV
Brittain, RT; Kellett, DN; Neat, ML; Stables, R. Anti-nociceptive effects in N-substituted cyclohexylmethylbenzamides. In Proceedings of the British Pharmacological Society Br. J. Pharmacol., 1 Sep 1973, 49 (1), 158P–159P. 208 kB. https://doi.org/10.1111/j.1476-5381.1973.tb08279.x #AH-7921
Hayes, AG; Tyers, M. Determination of receptors that mediate opiate side effects in the mouse Br. J. Pharmacol., 1 Jul 1983, 79 (3), 731–736. 711 kB. https://doi.org/10.1111/j.1476-5381.1983.tb10011.x
Fabregat-Safont, D; Carbón, X; Ventura, M; Fornís, I; Guillamón, E; Sancho, JV; Hernández, F; Ibáñez, M. Updating the list of known opioids through identification and characterization of the new opioid derivative 3,4-dichloro-N-(2-(diethylamino)cyclohexyl)-N-methylbenzamide (U-49900) Sci. Rep., 24 Jul 2017, 7 (1), 6338. 3.1 MB. https://doi.org/10.1038/s41598-017-06778-9 GC,LC,MS,NMR,other
EMCDDA. New drugs in Europe, 2012, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2013. 773 kB. #47
EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.
EMCDDA. New drugs in Europe, 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2014. 311 kB.
Jones, LE; Stewart, A; Peters, KL; McNaul, M; Speers, SJ; Fletcher, NC; Bell, SEJ. Infrared and Raman screening of seized novel psychoactive substances: a large scale study of >200 samples Analyst, 25 Jan 2016, 141 (3), 902–909. 1.3 MB. https://doi.org/10.1039/c5an02326b NMR,other
Zawilska, JB; Andrzejczak, D. Next generation of novel psychoactive substances on the horizon – A complex problem to face Drug Alcohol Depend., 1 Jan 2015, 157, 1-17. 3.0 MB. https://doi.org/10.1016/j.drugalcdep.2015.09.030
Sommerfeld-Klatta, K; Teżyk, A; Geppert, B. Toxicological analysis of new opioids In Chromatographic Techniques in the Forensic Analysis of Designer Drugs; Kowalska, T; Sajewicz, M; Sherma, J, Eds., CRC Press, Taylor & Francis Group, 1 Jan 2018; pp 391–417. 746 kB.
Kronstrand, R; Guerrieri, D; Vikingsson, S; Wohlfarth, A; Gréen, H. Fatal poisonings associated with new psychoactive substances In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 495–541. 477 kB. https://doi.org/10.1007/164_2018_110 #AH-7921
Kraemer, M; Boehmer, A; Madea, B; Maas, A. Death cases involving certain new psychoactive substances: A review of the literature Forensic Sci. Int., 1 May 2019, 298, 186–267. 6.7 MB. https://doi.org/10.1016/j.forsciint.2019.02.021 #AH-7921
Armenian, P; Vo, KT; Barr-Walker, J; Lynch, KL. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review Neuropharmacology, 1 May 2018, 134, 121–132. 847 kB. https://doi.org/10.1016/j.neuropharm.2017.10.016 #AH-7921
Sharma, KK; Hales, TG; Rao, VJ; NicDaeid, N; McKenzie, C. The search for the “next” euphoric non-fentanil novel synthetic opioids on the illicit drugs market: current status and horizon scanning Forensic Toxicol., 1 Jan 2019, 37 (1), 1–16. 1.1 MB. https://doi.org/10.1007/s11419-018-0454-5 #AH-7921
Middleton, SA; Kirby, DA. The synthesis and characterization of 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (AH-7921), a synthetic opiate JCLIC, 1 Oct 2014, 24 (4), 29-35. 1.2 MB. GC,LC,MS,NMR,IR
Hasegawa, K; Minakata, K; Suzuki, M; Suzuki, O. Non-fentanyl-derived synthetic opioids emerging during recent years Forensic Toxicol., 1 Jul 2022, 40 (2), 234–243. 1.6 MB. https://doi.org/10.1007/s11419-022-00624-y #Table S1 (1)